Signal detection and evaluation
Pharmacovigilance- Adverse drug reaction monitoring
Article REF: PHA3060 V1
Signal detection and evaluation
Pharmacovigilance- Adverse drug reaction monitoring

Author : Elisabeth POLARD

Publication date: June 10, 2016, Review date: May 27, 2020 | Lire en français

Logo Techniques de l'Ingenieur You do not have access to this resource.
Request your free trial access! Free trial

Already subscribed?

6. Signal detection and evaluation

Based on the analysis of data collected on ARs, particularly in terms of severity, novelty and frequency, ANSM must be alerted to a potential signal that could modify the benefit/risk ratio of the drug. If the signal is confirmed, thus becoming an alert, precautionary measures and/or preventive or corrective actions must be implemented.

6.1 Signal detection

Signal detection in pharmacovigilance involves highlighting any potential association between a drug and the AEs it is likely to cause, where this relationship is unknown or insufficiently documented. The signal may reveal a new iatrogenic effect of the drug, but also risk factors for its occurrence, drug interactions and so on.

Signals can be detected manually, by analyzing notifications...

You do not have access to this resource.
Logo Techniques de l'Ingenieur

Exclusive to subscribers. 97% yet to be discovered!

You do not have access to this resource. Click here to request your free trial access!

Already subscribed?


Article included in this offer

"Drugs and pharmaceuticals"

( 125 articles )

Complete knowledge base

Updated and enriched with articles validated by our scientific committees

Services

A set of exclusive tools to complement the resources

View offer details
Contact us